The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...
The Chosun Ilbo on MSN
Big Pharma competes in prostate cancer drug development
U.S. pharmaceutical company Johnson & Johnson (J&J) is conducting clinical trials for its prostate cancer (prostate gland ...
Denosumab treatment beyond 12 months was linked to higher jaw necrosis risk without further reduction in skeletal events in ...
In a prospective cohort, a 3-gene blood model predicted 1-year castration resistance with an AUC of 0.89 in metastatic ...
C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Explore integrative therapies for metastatic prostate cancer, including nutrition, acupuncture, supplements, exercise, and ...
The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...
Scientists have discovered vital clues to help predict, more than a decade in advance, which men may develop prostate cancer.
AstraZeneca has punted a pair of early-phase prostate cancer progra | AstraZeneca has punted a pair of early-phase prostate ...
We might wonder, could it be the vibration from the saws they are using?’ Alternatively, ‘Could it be the emissions from the ...
San Francisco 49ers tight end George Kittle has teamed up with Novartis to raise awareness of prostate cancer and highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results